| Patient | Sugar Ray Robinson |
|---|---|
| Date of birth | 1921-05-03 |
| Identifiers | MRN HR-BX003-SYN-TD; SSN (made up) 000-03-9318 |
| Document date | 2026-11-01 |
| Author | Langston Pryce-Okonjo, MD |
| Custodian | St. Posthumous Health Center |
Readable copy of the C-CDA narrative, generated with the XML. Coded entries are in the XML file beside this page.
Establishing care for memory loss and getting lost, with his care partner: cognitive testing, reversible causes, medicines, diabetes and blood pressure, driving and firearm safety. Concerns: He wants to know why he is forgetting and what can be done; He wants to keep his independence and keep working with the young fighters at the foundation; His care partner is worried about his driving and about managing alone. [S]
| Allergy | Reaction | Status | Evidence |
|---|---|---|---|
| No known allergy | active | S |
| Medication | Frequency | Route | Dates | Status | Evidence |
|---|---|---|---|---|---|
| Metformin 1,000 mg oral tablet, one tablet twice daily with meals | One tablet twice daily with meals | Oral route | 1982-03-01 | active | S |
| Glipizide 5 mg oral tablet, one tablet before breakfast | One tablet before breakfast | Oral route | 1983-01-15 to 1984-08-18 | completed | S |
| Lisinopril 20 mg oral tablet, one tablet daily | One tablet daily | Oral route | 1981-06-01 | active | S |
| Atorvastatin 20 mg oral tablet, one tablet daily | One tablet daily | Oral route | 1982-03-01 | active | S |
| Diphenhydramine 25 mg oral capsule, one at bedtime for sleep, bought over the counter | One capsule at bedtime | Oral route | 1983-10-01 to 1984-07-07 | stopped | S |
| Donepezil 5 mg oral tablet, one tablet at bedtime | One tablet at bedtime | Oral route | 1984-08-18 to 1984-09-22 | completed | S |
| Donepezil 10 mg oral tablet, one tablet at bedtime | One tablet at bedtime | Oral route | 1984-09-22 to 1984-10-01 | stopped | S |
| Donepezil 5 mg oral tablet, one tablet each morning with breakfast | One tablet each morning with breakfast | Oral route | 1984-10-01 | active | S |
| Procedure | Dates | Status | Evidence |
|---|---|---|---|
| MRI of the brain without contrast, with susceptibility-weighted imaging: moderate atrophy of both hippocampi, left more than right (medial temporal atrophy score 2 on each side), mild generalized atrophy, a few small white matter hyperintensities (Fazekas 1), six microbleeds at the gray-white junction of both frontal lobes and the right temporal lobe in a pattern seen after traumatic brain injury, no cortical superficial siderosis, no infarct, mass or hydrocephalus, and a cavum septi pellucidi, a finding common in boxers | 1984-07-21 to 1984-07-21 | completed | S |
| Pure tone audiometry: mild to moderate bilateral high-frequency sensorineural hearing loss, symmetric; speech understanding good in quiet, reduced in noise | 1984-07-21 to 1984-07-21 | completed | S |
| Amyloid PET with florbetapir: positive, with widespread cortical tracer uptake (about 90 Centiloids), confirming Alzheimer's disease pathology | 1984-08-04 to 1984-08-04 | completed | S |
| Twelve-lead ECG before donepezil: sinus rhythm at 70 per minute, PR interval 172 ms, QTc 414 ms, no conduction block | 1984-08-18 to 1984-08-18 | completed | S |
| Fitting of hearing aids for both ears by the audiologist, with teaching for him and his care partner | 1984-09-01 to 1984-09-01 | completed | S |
| Advance care planning conversation, about 30 minutes, with him and his care partner; his capacity to name a health care agent and state his values was assessed and present | 1984-09-08 to 1984-09-08 | completed | S |
| Twelve-lead ECG: sinus bradycardia at 56 per minute, PR interval 180 ms, QTc 420 ms, no heart block | 1984-10-01 to 1984-10-01 | completed | S |
| Date | Vaccine | Status | Evidence |
|---|---|---|---|
| 1984-09-08 | Influenza vaccine for the coming season | completed | S |
| 1984-09-08 | Pneumococcal conjugate vaccine (PCV20), recommended for all adults aged 50 and older | completed | S |
| 1984-09-08 | Recombinant zoster vaccine, first of two doses | completed | S |
| 1984-09-22 | Tdap vaccine, deferred from the preventive visit at his request | completed | S |
Historical biography with true dates. These events are not part of the synthetic care timeline.
| Historical date | History | Evidence |
|---|---|---|
| 1940 to 1965 | About 200 professional bouts over 25 years of boxing, after an amateur career: long exposure to repetitive head impacts; no source read records a knockout count with loss of consciousness or a brain injury diagnosis | D (CLM-0002, CLM-0004) |
No family medical history is documented in the logged sources. Family history of real relatives is recorded only from documented or retrospective sources and is never synthesized.
| Concern | Status | Evidence |
|---|---|---|
| He wants to know why he is forgetting and what can be done | active | S |
| He wants to keep his independence and keep working with the young fighters at the foundation | active | S |
| His care partner is worried about his driving and about managing alone | active | S |
Most recent measures: Leukocytes [#/volume] in Blood by Automated count 6.4 on 1984-07-07; Hemoglobin [Mass/volume] in Blood 14.1 on 1984-07-07; Platelets [#/volume] in Blood by Automated count 231 on 1984-07-07; Sodium [Moles/volume] in Serum or Plasma 138 on 1984-10-01; Potassium [Moles/volume] in Serum or Plasma 4.4 on 1984-10-27; Creatinine [Mass/volume] in Serum or Plasma 1 on 1984-10-27; Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI 1979)/1.73 sq M 85 on 1984-10-27; Glucose [Mass/volume] in Serum or Plasma 112 on 1984-10-01; Hemoglobin A1c/Hemoglobin.total in Blood 6.9 on 1984-09-22; Cobalamin (Vitamin B12) [Mass/volume] in Serum or Plasma 352 on 1984-07-07; Thyrotropin [Units/volume] in Serum or Plasma 1.9 on 1984-07-07; Albumin/Creatinine [Mass Ratio] in Urine 14 on 1984-07-07; Total score [MoCA] 18 on 1984-07-07; Patient Health Questionnaire 9 item (PHQ-9) total score [Reported] 3 on 1984-10-27; Mini-Mental State Examination [MMSE] 22 on 1984-07-21; Clinical Dementia Rating scale [CDR] 1 on 1984-07-21; Cholesterol [Mass/volume] in Serum or Plasma 154 on 1984-09-08; Cholesterol in HDL [Mass/volume] in Serum or Plasma 49 on 1984-09-08; Cholesterol in LDL [Mass/volume] in Serum or Plasma by calculation 79 on 1984-09-08; Triglyceride [Mass/volume] in Serum or Plasma 128 on 1984-09-08; Patient Health Questionnaire 2 item (PHQ-2) total score [Reported] 0 on 1984-09-08 [S]
Strengths and supports: Strengths and supports: discipline and daily exercise, pride in his career, a warm and sociable manner, his care partner, friends from boxing, and the young people at the foundation [S]
| Problem | Clinical status | Verification | Code | Provenance |
|---|---|---|---|---|
| Memory loss over about two years, worse in the past six months, with repeated questions, missed appointments and bills, and getting lost twice while driving in familiar streets, reported by him and his care partner; cause to be found | resolved | confirmed | R41.3 | S — Synthetic presenting problem anchored to his documented Alzheimer's disease; resolved into the diagnosis at the third visit. Not a claim about his real symptoms at that age. |
| Alzheimer's disease with early onset, confirmed by a positive amyloid PET, with an amnestic presentation; traumatic encephalopathy syndrome, a research diagnosis, considered | active | confirmed | G30.0 | S — Synthetic modern diagnosis by current criteria at the third visit; not a retrospective diagnosis of the historical person beyond the documented Alzheimer's disease. |
| Mild dementia due to Alzheimer's disease (CDR 1, MMSE 22, MoCA 18), without behavioral or psychological symptoms | active | confirmed | F02.A0 | S — Synthetic stage at diagnosis. |
| Type 2 diabetes for about ten years on metformin and glipizide; hemoglobin A1c 6.4%, below his goal, with hypoglycemia risk from the sulfonylurea | active | confirmed | E11.9 | S — Synthetic modern diabetes anchored to his documented diabetes. |
| Hypertension, controlled on lisinopril | active | confirmed | I10 | S — Synthetic modern hypertension anchored to the single press report. |
| Bilateral sensorineural hearing loss, mild to moderate, high frequencies, on audiometry | active | confirmed | H90.3 | S — Synthetic finding checked as a modifiable contributor to cognitive difficulty. |
| Nausea, loose stools, dizziness on standing and a slow pulse (56) nine days after donepezil was raised to 10 mg, with mild dehydration (creatinine 1.2 mg/dL); resolved after returning to 5 mg in the morning and two days of sick-day rules | resolved | confirmed | R11.0 | S — Synthetic adverse effect of a cholinesterase inhibitor; not a historical claim. |
| Date | Measure | Value | Unit | Reference range | Flag | Provenance |
|---|---|---|---|---|---|---|
| 1984-07-07 | Leukocytes [#/volume] in Blood by Automated count | 6.4 | 10*3/uL | 4-11 10*3/uL | Normal | S |
| 1984-07-07 | Hemoglobin [Mass/volume] in Blood | 14.1 | g/dL | 13.5-17.5 g/dL | Normal | S |
| 1984-07-07 | Platelets [#/volume] in Blood by Automated count | 231 | 10*3/uL | 150-400 10*3/uL | Normal | S |
| 1984-07-07 | Sodium [Moles/volume] in Serum or Plasma | 140 | mmol/L | 135-145 mmol/L | Normal | S |
| 1984-07-07 | Potassium [Moles/volume] in Serum or Plasma | 4.4 | mmol/L | 3.5-5.1 mmol/L | Normal | S |
| 1984-07-07 | Creatinine [Mass/volume] in Serum or Plasma | 1 | mg/dL | 0.74-1.35 mg/dL | Normal | S |
| 1984-07-07 | Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI 1979)/1.73 sq M | 85 | mL/min/{1.73_m2} | >=60 mL/min/1.73 m² | Normal | S |
| 1984-07-07 | Glucose [Mass/volume] in Serum or Plasma | 126 | mg/dL | 70-140 mg/dL | Normal | S |
| 1984-07-07 | Hemoglobin A1c/Hemoglobin.total in Blood | 6.4 | % | <=5.6% | High | S |
| 1984-07-07 | Cobalamin (Vitamin B12) [Mass/volume] in Serum or Plasma | 352 | pg/mL | 232-1245 pg/mL | Normal | S |
| 1984-07-07 | Thyrotropin [Units/volume] in Serum or Plasma | 1.9 | m[IU]/L | 0.45-4.5 mIU/L | Normal | S |
| 1984-07-07 | Albumin/Creatinine [Mass Ratio] in Urine | 14 | mg/g | <=29 mg/g | Normal | S |
| 1984-07-07 | Total score [MoCA] | 18 | {score} | S | ||
| 1984-07-07 | Patient Health Questionnaire 9 item (PHQ-9) total score [Reported] | 4 | {score} | S | ||
| 1984-07-21 | Mini-Mental State Examination [MMSE] | 22 | {score} | S | ||
| 1984-07-21 | Clinical Dementia Rating scale [CDR] | 1 | {score} | S | ||
| 1984-09-22 | Hemoglobin A1c/Hemoglobin.total in Blood | 6.9 | % | <=5.6% | High | S |
| 1984-10-01 | Sodium [Moles/volume] in Serum or Plasma | 138 | mmol/L | 135-145 mmol/L | Normal | S |
| 1984-10-01 | Potassium [Moles/volume] in Serum or Plasma | 4.6 | mmol/L | 3.5-5.1 mmol/L | Normal | S |
| 1984-10-01 | Creatinine [Mass/volume] in Serum or Plasma | 1.2 | mg/dL | 0.74-1.35 mg/dL | Normal | S |
| 1984-10-01 | Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI 1979)/1.73 sq M | 68 | mL/min/{1.73_m2} | >=60 mL/min/1.73 m² | Normal | S |
| 1984-10-01 | Glucose [Mass/volume] in Serum or Plasma | 112 | mg/dL | 70-140 mg/dL | Normal | S |
| 1984-10-27 | Potassium [Moles/volume] in Serum or Plasma | 4.4 | mmol/L | 3.5-5.1 mmol/L | Normal | S |
| 1984-10-27 | Creatinine [Mass/volume] in Serum or Plasma | 1 | mg/dL | 0.74-1.35 mg/dL | Normal | S |
| 1984-10-27 | Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI 1979)/1.73 sq M | 85 | mL/min/{1.73_m2} | >=60 mL/min/1.73 m² | Normal | S |
| 1984-10-27 | Patient Health Questionnaire 9 item (PHQ-9) total score [Reported] | 3 | {score} | S | ||
| 1984-09-08 | Cholesterol [Mass/volume] in Serum or Plasma | 154 | mg/dL | <=199 mg/dL | Normal | S |
| 1984-09-08 | Cholesterol in HDL [Mass/volume] in Serum or Plasma | 49 | mg/dL | >=40 mg/dL | Normal | S |
| 1984-09-08 | Cholesterol in LDL [Mass/volume] in Serum or Plasma by calculation | 79 | mg/dL | <=99 mg/dL | Normal | S |
| 1984-09-08 | Triglyceride [Mass/volume] in Serum or Plasma | 128 | mg/dL | <=149 mg/dL | Normal | S |
| 1984-09-08 | Patient Health Questionnaire 2 item (PHQ-2) total score [Reported] | 0 | {score} | S |
| Date | Measure | Value | Unit | Provenance |
|---|---|---|---|---|
| 1984-07-07 | Body height | 180 | cm | S |
| 1984-07-07 | Body weight | 77 | kg | S |
| 1984-07-07 | Body mass index (BMI) [Ratio] | 23.8 | kg/m2 | S |
| 1984-07-07 | Systolic blood pressure | 132 | mm[Hg] | S |
| 1984-07-07 | Diastolic blood pressure | 80 | mm[Hg] | S |
| 1984-07-07 | Heart rate | 72 | /min | S |
| 1984-07-07 | Respiratory rate | 14 | /min | S |
| 1984-07-07 | Body temperature | 36.7 | Cel | S |
| 1984-07-07 | Oxygen saturation in Arterial blood by Pulse oximetry | 98 | % | S |
| 1984-07-21 | Body height | 180 | cm | S |
| 1984-07-21 | Body weight | 76.8 | kg | S |
| 1984-07-21 | Body mass index (BMI) [Ratio] | 23.7 | kg/m2 | S |
| 1984-07-21 | Systolic blood pressure | 128 | mm[Hg] | S |
| 1984-07-21 | Diastolic blood pressure | 78 | mm[Hg] | S |
| 1984-07-21 | Heart rate | 70 | /min | S |
| 1984-07-21 | Respiratory rate | 14 | /min | S |
| 1984-07-21 | Body temperature | 36.6 | Cel | S |
| 1984-07-21 | Oxygen saturation in Arterial blood by Pulse oximetry | 98 | % | S |
| 1984-08-18 | Body height | 180 | cm | S |
| 1984-08-18 | Body weight | 76.6 | kg | S |
| 1984-08-18 | Body mass index (BMI) [Ratio] | 23.6 | kg/m2 | S |
| 1984-08-18 | Systolic blood pressure | 126 | mm[Hg] | S |
| 1984-08-18 | Diastolic blood pressure | 78 | mm[Hg] | S |
| 1984-08-18 | Heart rate | 70 | /min | S |
| 1984-08-18 | Respiratory rate | 14 | /min | S |
| 1984-08-18 | Body temperature | 36.6 | Cel | S |
| 1984-08-18 | Oxygen saturation in Arterial blood by Pulse oximetry | 98 | % | S |
| 1984-09-22 | Body height | 180 | cm | S |
| 1984-09-22 | Body weight | 76.2 | kg | S |
| 1984-09-22 | Body mass index (BMI) [Ratio] | 23.5 | kg/m2 | S |
| 1984-09-22 | Systolic blood pressure | 128 | mm[Hg] | S |
| 1984-09-22 | Diastolic blood pressure | 76 | mm[Hg] | S |
| 1984-09-22 | Heart rate | 64 | /min | S |
| 1984-09-22 | Respiratory rate | 14 | /min | S |
| 1984-09-22 | Body temperature | 36.6 | Cel | S |
| 1984-09-22 | Oxygen saturation in Arterial blood by Pulse oximetry | 98 | % | S |
| 1984-10-27 | Body height | 180 | cm | S |
| 1984-10-27 | Body weight | 75.8 | kg | S |
| 1984-10-27 | Body mass index (BMI) [Ratio] | 23.4 | kg/m2 | S |
| 1984-10-27 | Systolic blood pressure | 126 | mm[Hg] | S |
| 1984-10-27 | Diastolic blood pressure | 76 | mm[Hg] | S |
| 1984-10-27 | Heart rate | 66 | /min | S |
| 1984-10-27 | Respiratory rate | 14 | /min | S |
| 1984-10-27 | Body temperature | 36.5 | Cel | S |
| 1984-10-27 | Oxygen saturation in Arterial blood by Pulse oximetry | 98 | % | S |
| 1984-09-08 | Body height | 180 | cm | S |
| 1984-09-08 | Body weight | 76.4 | kg | S |
| 1984-09-08 | Body mass index (BMI) [Ratio] | 23.6 | kg/m2 | S |
| 1984-09-08 | Systolic blood pressure | 126 | mm[Hg] | S |
| 1984-09-08 | Diastolic blood pressure | 76 | mm[Hg] | S |
| 1984-09-08 | Heart rate | 68 | /min | S |
| 1984-09-08 | Respiratory rate | 14 | /min | S |
| 1984-09-08 | Body temperature | 36.6 | Cel | S |
| 1984-09-08 | Oxygen saturation in Arterial blood by Pulse oximetry | 98 | % | S |
| 1984-10-01 | Body height | 180 | cm | S |
| 1984-10-01 | Body weight | 74.6 | kg | S |
| 1984-10-01 | Body mass index (BMI) [Ratio] | 23 | kg/m2 | S |
| 1984-10-01 | Systolic blood pressure | 118 | mm[Hg] | S |
| 1984-10-01 | Diastolic blood pressure | 70 | mm[Hg] | S |
| 1984-10-01 | Heart rate | 56 | /min | S |
| 1984-10-01 | Respiratory rate | 16 | /min | S |
| 1984-10-01 | Body temperature | 36.8 | Cel | S |
| 1984-10-01 | Oxygen saturation in Arterial blood by Pulse oximetry | 98 | % | S |
| Date | Purpose | Status | Provenance |
|---|---|---|---|
| 1984-07-07 | Establishing care for memory loss and getting lost, with his care partner: cognitive testing, reversible causes, medicines, diabetes and blood pressure, driving and firearm safety | finished | S |
| 1984-07-21 | Two-week review, seen the same day by cognitive neurology: brain MRI, hearing test, staging, Alzheimer's disease against traumatic encephalopathy syndrome, and anti-amyloid eligibility | finished | S |
| 1984-08-18 | Six-week review: amyloid PET result, the diagnosis and the plan, with diabetes, driving, firearm and caregiver support | finished | S |
| 1984-09-22 | Eleven-week review: donepezil dose, diabetes, hearing aids and day program | finished | S |
| 1984-10-27 | Sixteen-week review: medicines, kidneys, mood, caregiver strain and the plan | finished | S |
| 1984-09-08 | Periodic adult preventive visit | finished | S |
| 1984-10-01 | Same-day sick visit for nausea and dizziness on donepezil | finished | S |
| Intervention | Status | Guideline | Provenance |
|---|---|---|---|
| Dementia work-up under the Alzheimer's Association guideline: history from him and his care partner, MoCA, function, depression screening, first-tier blood tests (blood count, metabolic panel, B12, TSH), a review of medicines for anticholinergic and sedating drugs, a sleep apnea screen, and brain MRI | completed | GL-ALZ-2024, GL-ALZ-PC-2024, GL-CMID-2026 | S |
| Cognitive neurology consultation at the memory clinic to stage the dementia, weigh Alzheimer's disease against traumatic encephalopathy syndrome and vascular disease, choose biomarker testing, and decide anti-amyloid eligibility | completed | GL-ALZ-2024, GL-TES-2021, GL-AUR-LEC-2023, GL-AUR-DON-2025 | S |
| Stop diphenhydramine, a strongly anticholinergic sleep aid; sleep habits and morning light instead | completed | GL-BEERS-2023 | S |
| Driving: no driving until the evaluation is complete, with his care partner driving; firearm: unloaded and locked, with the key held by his care partner, until a decision with him | completed | GL-AAN-DRIVING-2010, GL-ALZ-2024 | S |
| Amyloid PET to confirm Alzheimer's disease pathology; APOE genotyping not needed because he is not a candidate for anti-amyloid therapy, and offered only with counseling | completed | GL-ALZ-2024, GL-AUR-LEC-2023, GL-AUR-DON-2025 | S |
| Donepezil 5 mg at bedtime with a baseline ECG and pulse checks, raised to 10 mg after four to six weeks if tolerated; taken in the morning if dreams are vivid | completed | GL-ALZ-2024, GL-CMID-2026 | S |
| Diabetes deintensified under the ADA Standards for older adults: stop glipizide, continue metformin, hemoglobin A1c goal under 8.0%, sick-day rules (hold metformin when not eating or drinking), and B12 checked periodically | completed | GL-ADA-OLDER-2026, GL-CMID-2026 | S |
| Blood pressure under 130/80 mmHg on lisinopril, with potassium and creatinine checks | completed | GL-ADA-OLDER-2026, GL-CMID-2026 | S |
| Hearing aids for both ears, fitted by the audiologist | completed | GL-ALZ-2024 | S |
| Stop driving after the diagnosis (CDR 1 and getting lost), with transport planned; the handgun removed from the home | completed | GL-AAN-DRIVING-2010, GL-ALZ-2024 | S |
| Caregiver support: education, the Alzheimer's Association 24/7 Helpline, an adult day program for respite, a caregiver burden check, and the Medicare GUIDE dementia care model once he has Medicare | completed | GL-GUIDE, GL-ALZ-2024 | S |
| Advance care planning while he can take part fully: a health care agent and his values, at the preventive visit | completed | GL-ALZ-2024 | S |
| Exercise, social activity and diabetes and blood pressure control as the brain-health measures with the most support | completed | GL-ALZ-2024, GL-ADA-OLDER-2026 | S |
| Goal | Target | Status | Outcome | Provenance |
|---|---|---|---|---|
| Find the cause of the memory loss and explain it to him in a way he can take in | 1984-08-18 | completed | Alzheimer's disease confirmed by amyloid PET; disclosed with his care partner present, at his request, with written notes | S |
| No hypoglycemia, with hemoglobin A1c under 8.0% | 1984-10-27 | completed | Glipizide stopped after one reading of 68 mg/dL; no low readings since; A1c 6.4 to 6.9% | S |
| Stay safe: no driving and no firearm in the home | 1984-08-18 | completed | He stopped driving and the handgun was removed from the home | S |
| Keep his days full and give his care partner regular breaks | 1984-10-27 | completed | Adult day program two days a week; walks and the foundation gym on other days; Alzheimer's Association helpline | S |